Otitis media is a general term used to describe inflammation of the middle ear which may be caused by an acute infection.
The symptoms are usually nonspecific and include otalgia (pulling of ear in an infant), irritability, otorrhea with or without fever.
Symptoms of upper respiratory tract infection may also be present
In children with recurrent acute otitis media (rAOM), the presence of bacterial otopathogen, particularly nontypeable H. influenzae (NTHi), in the middle ear during ventilation tube insertion (VTI) is associated with repeat surgery, according to a recent study.
Children who undergo adenoidectomy, tonsillectomy, or both (adenotonsillectomy) within the first 9 years of life may have an elevated long-term risk of respiratory, allergic, or infectious diseases, results from a Denmark-based study show.
Not only are broad-spectrum antibiotics no better than narrow-spectrum antibiotics in reducing treatment failures and improving other patient-centred outcomes, their use may come with more side effects than narrow-spectrum antibiotics in children with acute respiratory tract infections (ARTIs), suggests a recent study.
In children with acute otitis media, antimicrobial treatment may be most beneficial in the presence of severe bulging of the tympanic membrane and be withheld in patients with peaked tympanogram, according to a study.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS JPOG - Malaysia digital copy today!
Having migraine during midlife appears to be associated with a higher risk of developing dementia in later life, according to a large population-based longitudinal Danish study presented at the AHS* 2020 Virtual Meeting, indicating that migraine may be a risk factor for dementia.
Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.
Pembrolizumab in combination with chemotherapy significantly improves progression-free survival (PFS) vs chemotherapy alone in patients with previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC), results of the KEYNOTE-355 study have shown.